Clinical Updates | January 20, 2021

Public Health and Scientific Challenges | IHS Epidemiology Update | Monoclonal Antibodies | January 7, 2021

In this series of presentations, Dr. Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases, discusses COVID-19 public health and scientific challenges. Then Dr. Michael Toedt, Medical Director for… […]

Read More… from Public Health and Scientific Challenges | IHS Epidemiology Update | Monoclonal Antibodies | January 7, 2021

Moderna COVID-19 Vaccine Safety and Efficacy Data | COVID-19 Vaccine FAQs and Answers | December 16, 2020

In this series of presentations, Dr. Alex Wu provides an update of the latest COVID-19 vaccine safety and efficacy data. Then, Tom Weiser, MD, answers previously submitted and real-time questions regarding… […]

Read More… from Moderna COVID-19 Vaccine Safety and Efficacy Data | COVID-19 Vaccine FAQs and Answers | December 16, 2020

Cultural Considerations in COVID-19 Occurrence in Special Populations and Potential Implications for Indian Country | CDC/FDA Updates | December 14, 2020

In this series of presentations, Dr. Thomas Becker, Medical Epidemiologist and ECHO faculty member, provides a summary and article review of cultural considerations in Covid-19 occurrence in special populations and… […]

Read More… from Cultural Considerations in COVID-19 Occurrence in Special Populations and Potential Implications for Indian Country | CDC/FDA Updates | December 14, 2020